Preclinical evaluation of ex vivo expanded/activated γδ T cells for immunotherapy of glioblastoma multiforme.
J. Neurooncol., Jan;101(2):179-88 (2011)
Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma.
Neuro-oncology., Aug;11(4):357-67 (2009)